Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INNOVA Project: low-dose naltrexone for fibromyalgia
2021-002534-16Phase 3Active
- Sponsor
- Fundació Sant Joan de Déu
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in fibromyalgia (FM) comparing Low-dose naltrexone + usual treatment with Placebo + usual treatment (2 arms). Primary endpoint: Pain intensity perception at the current moment. Started Aug 2021; status: active.
02
Drugs
naltrexone
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on 2021-002534-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002534-16.